{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,30]],"date-time":"2026-06-30T10:46:48Z","timestamp":1782816408895,"version":"3.54.5"},"reference-count":36,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2021,9,1]],"date-time":"2021-09-01T00:00:00Z","timestamp":1630454400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2021,9,1]],"date-time":"2021-09-01T00:00:00Z","timestamp":1630454400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2021,9,1]],"date-time":"2021-09-01T00:00:00Z","timestamp":1630454400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2021,9,1]],"date-time":"2021-09-01T00:00:00Z","timestamp":1630454400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2021,9,1]],"date-time":"2021-09-01T00:00:00Z","timestamp":1630454400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2021,9,1]],"date-time":"2021-09-01T00:00:00Z","timestamp":1630454400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2021,9,1]],"date-time":"2021-09-01T00:00:00Z","timestamp":1630454400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Bioorganic & Medicinal Chemistry Letters"],"published-print":{"date-parts":[[2021,9]]},"DOI":"10.1016\/j.bmcl.2021.128205","type":"journal-article","created":{"date-parts":[[2021,6,15]],"date-time":"2021-06-15T13:31:24Z","timestamp":1623763884000},"page":"128205","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":12,"special_numbering":"C","title":["The structural simplification of lysergic acid as a natural lead for synthesizing novel anti-Alzheimer agents"],"prefix":"10.1016","volume":"47","author":[{"given":"Muhammed","family":"Alzweiri","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Amsha","family":"S. Alsegiani","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Endri","family":"Karaj","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Daniyah","family":"A. Almarghalani","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yahia","family":"Tabaza","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zahoor","family":"A. Shah","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"L.M. Viranga","family":"Tillekeratne","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.bmcl.2021.128205_b0005","doi-asserted-by":"crossref","first-page":"100936","DOI":"10.1016\/j.arr.2019.100936","article-title":"Diabetes drugs in the fight against Alzheimer\u2019s disease","volume":"54","author":"Boccardi","year":"2019","journal-title":"Ageing Res Rev"},{"issue":"2","key":"10.1016\/j.bmcl.2021.128205_b0010","doi-asserted-by":"crossref","first-page":"223","DOI":"10.1016\/j.drudis.2016.10.010","article-title":"Amyloid beta modulators and neuroprotection in Alzheimer\u2019s disease: a critical appraisal","volume":"22","author":"Kuruva","year":"2017","journal-title":"Drug Discov Today"},{"issue":"pand695","key":"10.1016\/j.bmcl.2021.128205_b0015","first-page":"100","article-title":"Connexins and pannexins in Alzheimer\u2019s disease","volume":"16","author":"Giaume","year":"2017","journal-title":"Neurosci Lett"},{"issue":"2","key":"10.1016\/j.bmcl.2021.128205_b0020","doi-asserted-by":"crossref","first-page":"99","DOI":"10.1016\/j.trci.2016.05.001","article-title":"The roles of inflammation and immune mechanisms in Alzheimer\u2019s disease Alzheimer\u2019s Dement","volume":"2","author":"Van Eldik","year":"2016","journal-title":"Transl Res Clin Interv"},{"issue":"4","key":"10.1016\/j.bmcl.2021.128205_b0025","doi-asserted-by":"crossref","first-page":"159","DOI":"10.1159\/000078501","article-title":"Nonsteroidal anti-inflammatory drugs for the prevention of Alzheimer\u2019s disease: a systematic review","volume":"23","author":"Szekely","year":"2004","journal-title":"Neuroepidemiology"},{"issue":"6","key":"10.1016\/j.bmcl.2021.128205_b0030","doi-asserted-by":"crossref","first-page":"681","DOI":"10.1038\/nm1781","article-title":"Blocking TGF-\u03b2\u2013Smad2\/3 innate immune signaling mitigates alzheimer-like pathology","volume":"14","author":"Town","year":"2008","journal-title":"Nat Med"},{"issue":"3","key":"10.1016\/j.bmcl.2021.128205_b0035","doi-asserted-by":"crossref","first-page":"534","DOI":"10.1016\/j.neuron.2014.12.068","article-title":"Il10 deficiency rebalances innate immunity to mitigate alzheimer-like pathology","volume":"85","author":"Guillot-Sestier","year":"2015","journal-title":"Neuron"},{"key":"10.1016\/j.bmcl.2021.128205_b0040","doi-asserted-by":"crossref","first-page":"186","DOI":"10.1016\/j.neulet.2016.06.040","article-title":"Down-regulation of BNIP3 by olomoucine, a CDK inhibitor, reduces LPS-and NO-induced cell death in BV2 microglial cells","volume":"628","author":"Tsou","year":"2016","journal-title":"Neurosci Lett"},{"issue":"s2","key":"10.1016\/j.bmcl.2021.128205_b0045","doi-asserted-by":"crossref","first-page":"S231","DOI":"10.3233\/JAD-2012-111727","article-title":"Triangulated Mal-signaling in Alzheimer\u2019s disease: roles of neurotoxic ceramides, ER stress, and insulin resistance reviewed","volume":"30","author":"de la Monte","year":"2012","journal-title":"J Alzheimer\u2019s Dis"},{"issue":"2","key":"10.1016\/j.bmcl.2021.128205_b0050","doi-asserted-by":"crossref","first-page":"318","DOI":"10.1007\/s12640-018-9956-5","article-title":"Amelioration of aluminum maltolate-induced inflammation and endoplasmic reticulum stress-mediated apoptosis by tannoid principles of emblica officinalis in neuronal cellular model","volume":"35","author":"Bharathi","year":"2019","journal-title":"Neurotox Res"},{"issue":"5","key":"10.1016\/j.bmcl.2021.128205_b0055","first-page":"443","article-title":"Protein Folding in the ER. In Seminars in cell & developmental biology","volume":"10","author":"Stevens","year":"1999","journal-title":"Elsevier"},{"issue":"1","key":"10.1016\/j.bmcl.2021.128205_b0060","doi-asserted-by":"crossref","first-page":"81","DOI":"10.1016\/j.abb.2003.11.003","article-title":"TMX, a human transmembrane oxidoreductase of the thioredoxin family: the possible role in disulfide-linked protein folding in the endoplasmic reticulum","volume":"423","author":"Matsuo","year":"2004","journal-title":"Arch Biochem Biophys"},{"issue":"4","key":"10.1016\/j.bmcl.2021.128205_b0065","doi-asserted-by":"crossref","first-page":"372","DOI":"10.1038\/sj.cdd.4401378","article-title":"Coupling endoplasmic reticulum stress to the cell death program","volume":"11","author":"Rao","year":"2004","journal-title":"Cell Death Differ"},{"issue":"8","key":"10.1016\/j.bmcl.2021.128205_b0070","doi-asserted-by":"crossref","first-page":"1295","DOI":"10.1016\/j.biocel.2012.04.023","article-title":"Endoplasmic reticulum: the unfolded protein response is tangled in neurodegeneration","volume":"44","author":"Hoozemans","year":"2012","journal-title":"Int J Biochem Cell Biol"},{"issue":"1","key":"10.1016\/j.bmcl.2021.128205_b0075","doi-asserted-by":"crossref","first-page":"79","DOI":"10.2174\/156652406775574550","article-title":"ER stress and UPR in familial amyotrophic lateral sclerosis","volume":"6","author":"Turner","year":"2006","journal-title":"Curr Mol Med"},{"issue":"12","key":"10.1016\/j.bmcl.2021.128205_b0080","doi-asserted-by":"crossref","first-page":"1814","DOI":"10.1002\/elps.201100565","article-title":"Proteome analysis of tunicamycin-induced ER stress","volume":"33","author":"Bull","year":"2012","journal-title":"Electrophoresis"},{"issue":"10","key":"10.1016\/j.bmcl.2021.128205_b0085","doi-asserted-by":"crossref","first-page":"1801","DOI":"10.4161\/auto.32136","article-title":"Endoplasmic reticulum stress induced by tunicamycin and thapsigargin protects against transient ischemic brain injury: involvement of PARK2-dependent mitophagy","volume":"10","author":"Zhang","year":"2014","journal-title":"Autophagy"},{"issue":"2","key":"10.1016\/j.bmcl.2021.128205_b0090","doi-asserted-by":"crossref","first-page":"145","DOI":"10.1016\/j.cyto.2008.01.006","article-title":"LPS\/TLR4 signal transduction pathway","volume":"42","author":"Lu","year":"2008","journal-title":"Cytokine"},{"key":"10.1016\/j.bmcl.2021.128205_b0095","doi-asserted-by":"crossref","first-page":"124","DOI":"10.1016\/j.chroma.2017.05.043","article-title":"Lysergic acid amide as chemical marker for the total ergot alkaloids in rye flour-determination by high-performance thin-layer chromatography-fluorescence detection","volume":"1507","author":"Oellig","year":"2017","journal-title":"J Chromatogr A"},{"issue":"12","key":"10.1016\/j.bmcl.2021.128205_b0100","doi-asserted-by":"crossref","first-page":"4415","DOI":"10.5958\/0974-360X.2017.00814.9","article-title":"A brief review of chemistry and pharmacology of lysergic acid diethylamide","volume":"10","author":"Jadhav","year":"2017","journal-title":"Res J Pharm Technol"},{"key":"10.1016\/j.bmcl.2021.128205_b0105","doi-asserted-by":"crossref","unstructured":"Wallach, J.; Colestock, T.; Adejare, A. Receptor Targets in Alzheimer\u2019s Disease Drug Discovery. In Drug Discovery Approaches for the Treatment of Neurodegenerative Disorders; Elsevier, 2017; pp 83\u2013107.","DOI":"10.1016\/B978-0-12-802810-0.00006-4"},{"issue":"1","key":"10.1016\/j.bmcl.2021.128205_b0110","article-title":"Idalopirdine (LY483518, SGS518, Lu AE 58054) in Alzheimer rials","volume":"2","author":"Hesselink","year":"2016","journal-title":"J Pharmacol Clin Res"},{"issue":"5","key":"10.1016\/j.bmcl.2021.128205_b0115","first-page":"7293","article-title":"Ameliorative effect of nicergoline on cognitive function through the PI3K\/AKT signaling pathway in mouse models of Alzheimer\u2019s disease","volume":"17","author":"Zang","year":"2018","journal-title":"Mol Med Rep"},{"issue":"35","key":"10.1016\/j.bmcl.2021.128205_b0120","doi-asserted-by":"crossref","first-page":"5887","DOI":"10.2174\/0929867326666190618113613","article-title":"Natural products as potential anti-alzheimer agents","volume":"27","author":"Panda","year":"2019","journal-title":"Curr Med Chem"},{"issue":"7","key":"10.1016\/j.bmcl.2021.128205_b0125","doi-asserted-by":"crossref","DOI":"10.1002\/cbdv.201900144","article-title":"Design, synthesis, and cholinesterase inhibition assay of coumarin-3-carboxamide-n-morpholine hybrids as new anti-alzheimer agents","volume":"16","author":"Tehrani","year":"2019","journal-title":"Chem Biodivers"},{"issue":"9","key":"10.1016\/j.bmcl.2021.128205_b0130","doi-asserted-by":"crossref","first-page":"1189","DOI":"10.1021\/jo01091a005","article-title":"Synthesis of some 2-(3-Indolylethenyl)-and 2-(2-Pyrrylethenyl)-pyridines and hydrogenated analogs","volume":"24","author":"Castle","year":"1959","journal-title":"J Org Chem"},{"issue":"7","key":"10.1016\/j.bmcl.2021.128205_b0135","doi-asserted-by":"crossref","first-page":"645","DOI":"10.1002\/jps.2600520709","article-title":"Open-chain analogs of LSD II. Synthesis of some 2-(3-indolylethyl)-and 2-(3-methyl-2-indolylethyl) piperidines","volume":"52","author":"Whittle","year":"1963","journal-title":"J Pharm Sci"},{"issue":"6","key":"10.1016\/j.bmcl.2021.128205_b0140","doi-asserted-by":"crossref","first-page":"809","DOI":"10.1002\/jps.2600600602","article-title":"Structural analogs of lysergic acid","volume":"60","author":"Campaigne","year":"1971","journal-title":"J Pharm Sci"},{"issue":"13","key":"10.1016\/j.bmcl.2021.128205_b0145","doi-asserted-by":"crossref","first-page":"6265","DOI":"10.1021\/acs.jmedchem.6b00478","article-title":"Gramine derivatives targeting Ca2+ channels and Ser\/Thr phosphatases: a new dual strategy for the treatment of neurodegenerative diseases","volume":"59","author":"Lajar\u00edn-Cuesta","year":"2016","journal-title":"J Med Chem"},{"issue":"3","key":"10.1016\/j.bmcl.2021.128205_b0150","doi-asserted-by":"crossref","first-page":"841","DOI":"10.1007\/s00213-019-05417-7","article-title":"Safety, tolerability, pharmacokinetics, and pharmacodynamics of low dose lysergic acid diethylamide (LSD) in healthy older volunteers","volume":"237","author":"Family","year":"2020","journal-title":"Psychopharmacology"},{"issue":"1","key":"10.1016\/j.bmcl.2021.128205_b0155","doi-asserted-by":"crossref","first-page":"107","DOI":"10.1021\/jm50008a009","article-title":"Derivatives of N-Methylpiperidine","volume":"2","author":"Lasslo","year":"1959","journal-title":"J Med Chem"},{"issue":"5","key":"10.1016\/j.bmcl.2021.128205_b9000","doi-asserted-by":"crossref","first-page":"314","DOI":"10.1021\/ar980063a","article-title":"Anionic Pd(0) and Pd(II)Intermediates in Palladium-Catalyzed Heck and Cross-Coupling Reactions","volume":"33","author":"Amatore","year":"2000","journal-title":"Acc Chem Res"},{"issue":"3","key":"10.1016\/j.bmcl.2021.128205_b0160","doi-asserted-by":"crossref","first-page":"241","DOI":"10.1016\/0014-2999(94)90549-5","article-title":"Neuroprotective efficacy of n\u03c9-nitro-L-arginine after focal cerebral ischemia in the mouse and inhibition of cortical nitric oxide synthase","volume":"256","author":"Carreau","year":"1994","journal-title":"Eur J Pharmacol"},{"issue":"1\u20132","key":"10.1016\/j.bmcl.2021.128205_b0165","doi-asserted-by":"crossref","first-page":"35","DOI":"10.1016\/0006-8993(92)90924-X","article-title":"The neuroprotective actions of 2, 3-dihydroxy-6-nitro-7-sulfamoyl-benzo (F) quinoxaline (NBQX) in a rat focal ischaemia model","volume":"580","author":"Gill","year":"1992","journal-title":"Brain Res"},{"issue":"9","key":"10.1016\/j.bmcl.2021.128205_b0170","doi-asserted-by":"crossref","first-page":"1199","DOI":"10.3390\/nu10091199","article-title":"Metabolically healthy versus unhealthy morbidly obese: chronic inflammation, nitro-oxidative stress, and insulin resistance","volume":"10","author":"C\u04d1toi","year":"2018","journal-title":"Nutrients"},{"key":"10.1016\/j.bmcl.2021.128205_b0175","first-page":"415","article-title":"Inhibitory action of nicergoline and its major metabolites on acetylcholinesterase activity in rat and mouse brain","volume":"2","author":"Matsuoka","year":"1990","journal-title":"Basic Clin Ther Asp Alzheimer\u2019s Park Dis"}],"container-title":["Bioorganic & Medicinal Chemistry Letters"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0960894X21004327?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0960894X21004327?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,18]],"date-time":"2025-10-18T07:41:23Z","timestamp":1760773283000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0960894X21004327"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,9]]},"references-count":36,"alternative-id":["S0960894X21004327"],"URL":"https:\/\/doi.org\/10.1016\/j.bmcl.2021.128205","relation":{},"ISSN":["0960-894X"],"issn-type":[{"value":"0960-894X","type":"print"}],"subject":[],"published":{"date-parts":[[2021,9]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"The structural simplification of lysergic acid as a natural lead for synthesizing novel anti-Alzheimer agents","name":"articletitle","label":"Article Title"},{"value":"Bioorganic & Medicinal Chemistry Letters","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.bmcl.2021.128205","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2021 Elsevier Ltd. All rights reserved.","name":"copyright","label":"Copyright"}],"article-number":"128205"}}